The 12 closest competitors and alternatives to Brio Health, Inc. among medical devices companies — ranked by similarity to what Brio Health, Inc. actually does, not by market-cap band.
Subscribe to see Brio Health, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Brio Health, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $93,000 in July 2026. Xcout tracks 6 named people at Brio Health, Inc., including Chen Chen (CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $93,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Brio Health, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Corvion Inc., formerly known as EverHeart Systems, is headquartered in Webster, Texas, and develops fully implanted mechanical circulatory support devices. Its flagship product, the Corvion LVAD, is designed to serve as a successful circulatory support device for severe heart failure.
Similar medical devices company
V-Wave is a medical technology company established in Israel in 2009 that develops percutaneous implantable shunts and technologies for patients with chronic heart failure.
Similar medical devices company
BioVentrix, Inc. is a privately held specialty medical device company headquartered in Mansfield, Massachusetts. The firm serves cardiothoracic surgeons and patients by developing lifesaving therapies for heart failure.
Similar medical devices company
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Similar medical devices company
Procyrion, Inc. is a Houston, Texas-based heart pump developer. The company focuses on the research, expansion, and development of its Aortix circulatory support device for investigational use.
Medical Device
Alleviant Medical, Inc. is a medical device and clinical trial company headquartered in Austin, Texas, focused on heart failure solutions.
Similar medical devices company
Restore Medical is a clinical-stage medical technology company based in Israel that develops cardiac implants and transcatheter therapies for the treatment of congestive heart failure.
Similar medical devices company
Capstan Medical is a medical-device company developing minimally invasive, catheter-based systems for transcatheter mitral valve replacement. Its technology is intended for patients with mitral valve disease and the clinicians who treat them, particularly those who may be at elevated risk for open-heart surgery.
Similar medical devices company
Dynama, Inc. develops the Dynama System, an investigational medical device designed to relieve heart failure symptoms and reduce elevated left atrial pressure by creating a pathway in the upper chambers of the heart. The company primarily serves heart failure patients through clinical studies, such as the EASE HF2 feasibility study, to evaluate the safety and efficacy of its technology.
Similar medical devices company
Foldax, Inc. is an award-winning medical device company headquartered in Salt Lake City, Utah. The company specializes in the development and manufacturing of innovative Tria heart valves.
Therapeutic Devices
FlowMod is a company formed through a collaboration between Ajax Health, KKR, and Boston Scientific to develop a minimally invasive, catheter-based system for treating acute decompensated heart failure. The organization aims to accelerate the creation, clinical validation, and regulatory approval of this heart failure treatment system.
Similar medical devices company
VQ Biomedical develops a minimally-invasive intravascular oxygenation catheter designed to deliver supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure. The technology provides gas exchange independently of injured lungs to support healing while avoiding the complications of mechanical ventilation or external ECMO pumps. The company serves healthcare providers and critical care patients.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Brio Health, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →